Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1991
Chemoembolism in cancer chemotherapyD J Kerr, S B Kaye
Seminars in Oncology|October 26, 2000
Immunotherapy for colorectal cancer: potential application in an adjuvant settingD J Kerr, R S Midgley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Hepatic arterial chemotherapy: still on trialD J Kerr, R J McArdle
BMJ (Clinical Research Ed.)|January 15, 1994
Multidrug resistance in cancerD R Ferry, D J Kerr
Lancet (London, England)|November 17, 1984
Is the TRH test usually unnecessary?D J Kerr, W D Alexander
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?E C Johnstone, D J Kerr
Blood Reviews|March 1, 1991
Multidrug resistance: clinical relevance in haematological malignanciesS B Kaye, D J Kerr
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
Variation in the availability of cancer drug generics in the United States of AmericaA M Elzawawy, D J Kerr
In Vivo (Athens, Greece)|July 1, 1991
The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivoD J Kerr, H E Smart
Hospital Medicine (London, England : 1998)|November 26, 1998
Novel therapeutic strategies for colorectal cancerD J Kerr, D R Ferry
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1991
Chemoembolism in cancer chemotherapyD J Kerr, S B Kaye
Seminars in Oncology|October 26, 2000
Immunotherapy for colorectal cancer: potential application in an adjuvant settingD J Kerr, R S Midgley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Hepatic arterial chemotherapy: still on trialD J Kerr, R J McArdle
BMJ (Clinical Research Ed.)|January 15, 1994
Multidrug resistance in cancerD R Ferry, D J Kerr
Lancet (London, England)|November 17, 1984
Is the TRH test usually unnecessary?D J Kerr, W D Alexander
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?E C Johnstone, D J Kerr
Blood Reviews|March 1, 1991
Multidrug resistance: clinical relevance in haematological malignanciesS B Kaye, D J Kerr
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
Variation in the availability of cancer drug generics in the United States of AmericaA M Elzawawy, D J Kerr
In Vivo (Athens, Greece)|July 1, 1991
The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivoD J Kerr, H E Smart
Hospital Medicine (London, England : 1998)|November 26, 1998
Novel therapeutic strategies for colorectal cancerD J Kerr, D R Ferry
Pageof 23